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Abstract. p75NTR, a member of the tumor necrosis factor 
superfamily, plays a key role in numerous physiological 
processes, including cell survival or apoptosis. Yet, the associ-
ated signaling pathways remain poorly understood. Similar 
to Notch, γ-secretase cleavage is implicated in the p75NTR 
signaling pathway leading to nuclear translocation of the 
intracellular domain and cell death. Fas receptor activation 
was found to promote cell death apoptosis in several cell lines. 
The goal of this study was to determine the respective role of 
p75NTR and Notch in the resistance to Fas-induced apoptosis 
in the U-87 MG glioblastoma cell line. Using the γ-secretase 
inhibitor, we investigated the modulation of Fas-induced 
apoptosis dependent on p75NTR-Fas receptor interaction. 
Whereas the U-87 MG cells expressed the Fas receptor at 
the cell membrane, apoptosis induced by Fas activation was 
decreased by the γ-secretase inhibitor. These data suggest that 
γ-secretase is implicated in p75NTR and Fas interaction leading 
to cell death signaling.
Introduction
Glioblastoma, a brain tumor that develops from glial cells, 
mostly in adults, is considered to be the most malignant form 
of gliomas, which represent half of all primitive brain tumors. 
Its poor prognosis is related to the high malignant status and 
the absence of effective therapies, explained by their intrinsic 
resistance to many cytotoxic agents (1,2). As the development 
of new therapeutic strategies is of crucial importance, the 
mechanisms underlying the resistance to apoptosis induction 
need to be elucidated in order to define potential strategies 
involving therapeutic association of molecules, such as those 
related to Fas-mediated apoptosis. The Fas receptor, a member 
of the tumor-necrosis factor receptor superfamily, mediates 
apoptosis in certain sensitive cells when it is activated by 
Fas ligand (FasL). Therefore, it has been implicated in tumor 
regression, such as in glioma, especially when used in combi-
nation with other therapeutic molecules, such as etoposide and 
dexamethasone as reported in an experimental model of glio-
blastoma in the nude rat (3). However, potential residual tumor 
cells may reduce survival depending on fine interactions that 
counterbalance the Fas-signaling pathway. Accordingly, in 
another malignant cell line, a neuroblastoma line, we reported 
that the Fas receptor interacts with the p75NTR receptor inhib-
iting Fas-induced apoptosis (4). This resistance to cell death 
was effective through co-activation of p75NTR, another cell 
death receptor for neurotrophins, and the Fas receptor, by 
their natural ligands, BDNF and FasL, respectively, allowing 
that the Fas and p75NTR pathways are interactive (4). This dual 
function of p75NTR in apoptosis induction or cell growth and 
survival is in part due to its transcriptional function resulting 
from sequential α and γ-secretase actions that cleave p75NTR 
in the 24-kDa C-terminal fragment and a 19-kDa intracellular 
domain (ICD) fragment. ICD is translocated into the nucleus 
(5), where it modulates transcriptional events (6). Recent 
studies have demonstrated that p75NTR is a critical regulator of 
glioma invasion (7) endogenously expressed in patient tumors 
(8). Its biological function in invasion and tumor growth is 
related to its proteolytic processing by γ-secretase, leading 
to invasiveness and cell migration and their suppression by 
γ-secretase inhibitors (8). In addition, γ-secretase inhibi-
tors were found to increase radiosensitivity of glioblastoma, 
and induce reduction in CD133+-related stem cells (9). As 
proteolysis through γ-secretase activity is a highly conserved 
mechanism responsible for intramembrane cleavage of several 
proteins, such as β-amyloid precursor protein, ErbB4, CD44 
and Notch receptor (10), it was speculated by Lin et al that 
γ-secretase inhibitors inhibit CD133+ glioblastoma cell lines 
through inhibition of the Notch signaling pathway (9).
Notch signaling plays a key role in the normal development 
of many tissues and cell types, through effects on differentia-
tion, survival and/or proliferation that are highly dependent on 
signal strength and cellular context (11). Perturbations in the 
regulation of cellular homeostasis trigger malignant transfor-
mation. Moreover, Notch1 signaling potentially contributes 
to cancer development in several different pathways by 
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activating mitogen-activated protein kinase/phosphatidylino-
sitol 3-kinase-Akt pathways and up-regulating N-cadherin, or 
by acting on Myc transcription (12).
Accumulating data indicate that deregulated Notch or 
p75NTR activities may be involved in human cancer, such as 
glioblastoma (8). In order to improve glioblastoma therapy and 
patient care, diagnostic and prognostic factors are required.
The goal of the present study was to determine the respec-
tive role of p75NTR and Notch in the resistance to Fas-induced 
apoptosis in the U-87 MG glioblastoma cell line. Using 
the γ-secretase inhibitor, we searched for a modulation of 
Fas-induced apoptosis dependent on p75NTR-Fas receptor 
interaction.
We reported herein that the γ-secretase inhibitor dimin-
ished apoptosis through Fas activation and we hypothesized 
that the suppression of the proteolysis of p75NTR interferes with 
the Fas-p75NTR recruitment of apoptosis.
Materials and methods
Cell line culture and treatments. U-87 MG human glio-
blastoma cells (ATCC, Manassas, VA, USA) were cultured 
in MEM with Earl's salts (Invitrogen) supplemented with 
10% decomplemented foetal calf serum (FCS; Seromed, 
Invitrogen), 1.5 g/l sodium bicarbonate, 1% non-essential 
amino acids, sodium pyruvate (1 mM), penicillin (50 U/ml), 
streptomycin (50 µg/ml), L-glutamine (2 mM) and fungizone 
(0.1%) (Invitrogen). Cells were grown in 25-cm2 flasks (Nunc, 
France) at 37˚C in a humidified 5% CO2-95% air incubator. 
At subconfluence, cells were always recovered with versene 
(Invitrogen) and cultured in Lab-Tek chamber slides (Nunc) 
at 104 cells/well or in 6-well plates (Nunc) at 105 cells/well for 
48 h and were treated for 24 h with 7C11, an agonistic anti-Fas 
monoclonal antibody (mAb) at 100 ng/ml (Beckman Coulter 
Inc., Fullerton, CA, USA), the γ-secretase inhibitor at 1 µM 
(Calbiochem, France) or both molecules.
Flow cytometry. U-87 MG cells were cultured in 6-well plates 
(105 cells/well) at basal state or stimulated by agonistic anti-
Fas mAb or a γ-secretase inhibitor or both molecules during 
24 h. U-87 MG cells were first released with versene permea-
bilized or not using Triton X-100 (0.1%; Promega, France) 
and resuspended in 10% FCS/90% versene with either rabbit 
anti-Notch1 (C-20 or H131, 1/100; Santa Cruz Biotechnology), 
anti-Notch2 (25-255, 1/100; Santa Cruz Biotechnology), anti-
Delta1 (H-265, 1/100; Santa Cruz Biotechnology), anti-Delta4 
(H-70, 1/100; Santa Cruz Biotechnology), anti-Jagged1 (H-114, 
1/100; Santa Cruz Biotechnology) or anti-Jagged2 (H-143, 
1/100; Santa Cruz Biotechnology) polyclonal antibodies (Abs). 
Two anti-Fas mAb phycoerythrin (PE)-conjugated recog-
nizing the N- or C-terminus domain (UB2, 1/5; Immunotech, 
Marseille, France; or B-10, 1/50; Santa Cruz Biotechnology) 
were used. p75NTR expression was studied with an anti-p75NTR 
polyclonal Abs (H-137, 1/20; Santa Cruz Biotechnology) 
directed against the extracellular domain of p75NTR. Immature 
cell marker, an anti-vimentin mAb (1/50; Santa Cruz 
Biotechnology) was also evaluated. Controls were performed 
with rabbit irrelevant Ig (Santa Cruz Biotechnology) or mouse 
irrelevant Ig as isotypic controls. After a 30-min incubation 
on ice, non-conjugated-rabbit Abs were detected with a swine 
anti-rabbit Ig fluorescein isothiocyanate (FITC)-conjugated 
antibody (Dako-Cytomation, Trappes, France) diluted at 
1/100, in 10% FCS in versene during 30 min on ice. Finally, 
cells were resuspended in 10% FCS/90% versene. Each 
analysis was performed on at least 10,000 cells and repeated 
three times. Relative fluorescence intensity was measured by 
fluorescence-activated cell sorter analysis (Cytomics FC200; 
Beckman Coulter and LSR Fortessa, BD).
Assessment of in vitro apoptosis induction. To determine 
the apoptotic effect of Fas activation, cells were stimulated 
for 24 h with 7C11 mAb or a γ-secretase inhibitor alone or 
with both molecules. Two methods were used: i) Soluble 
cytoplasmic nucleosome detection. After a 24-h treatment of 
cells as described above, the rate of apoptosis was measured 
using cell death detection ELISA Plus (Roche Diagnostic, 
Meylan, France) according to the manufacturer's instructions. 
ii) Annexin-V staining. After two washes in PBS, cells were 
incubated with Annexin V-FITC (Beckman Coulter) solution 
(a marker of phosphatidylserine exposure to the cell membrane 
during early apoptotic process) containing propidium iodide 
(a DNA-intercalating dye to detect necrotic cells) for 15 min 
on ice. Cells were washed according to the manufacturer's 
instructions and analysis was directly performed by flow 
cytometry (Cytomics FC200; Beckman Coulter).
Cell cycle analysis. After a 24-h stimulation with 7C11, cell 
cycle analysis was performed using propidium iodide cell 
incorporation during 15 min and flow cytometric analysis 
(Cytomics FC200).
Statistical analyses. Each assay was performed at least in trip-
licate. For direct comparison of the apoptosis level according to 
the different conditions of treatment (Basal, 7C11, γ-secretase 
inhibitor and 7C11 + γ-secretase inhibitor), statistical signifi-
cance was determined by one-way analysis of variance with 
Statview 5.0 software. A value of p<0.05 was considered to 
denote statistical significance.
Results
Fas and p75NTR membrane expression in the U-87 MG cell 
line. Flow cytometry was performed using anti-Fas and p75NTR 
extracellular domain antibodies. As expected, Fas was detected 
at the membrane level (3) with ~100% of Fas-expressing cells 
(Fig. 1A). To determine that the Fas receptor was the full 
length receptor, potentially functional, and not a truncated 
form of Fas, staining was performed using specific mAb 
directed against anti-intracellular domain of Fas, recognizing 
the death domain. Data showed similar patterns of staining to 
those obtained with extracellular anti-Fas mAb, assessing that 
Fas expressed in U-87 MG cells deals with the full-length Fas 
protein containing the death domain (Fig. 1B).
In parallel, we searched for p75NTR expression in U-87 
MG cells. By contrast, by flow cytometry only 15% of cells 
expressed p75NTR at the membrane level, while 70% was 
detected after cell permeabilization (Fig. 1C and D), as 
previously described (13). In order to search for potential 
interactions with the Notch pathway during Fas activation, we 
studied Notch expression in U-87 MG cells.
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Notch1, 2 and their ligands are sequestered in the U-87 MG 
cells. Using specific antibodies directed against extracellular 
domains of Notch by flow cytometry (Fig. 2) or immunocyto-
chemical (data not shown) methods, we did not detect Notch1 
as well as Notch2 expression on the cell membrane (Fig. 2A). 
By contrast, Notch1 and Notch2 proteins were only detected 
after cell permeabilization in U-87 MG cells. Their detection 
with extracellular- and intracellular-specific anti-Notch Abs in 
U-87 MG permeabilized cells confirmed that their full-length 
proteins were sequestered into the cytoplasm (Fig. 2B). In 
addition, we confirmed by flow cytometry that Notch ligands 
Delta 1 and 4 and Jagged 1 and 2 were also expressed in intra-
cellular compartments of U-87 MG cells (Fig. 2C).
Fas activation induces apoptosis without modifying cell 
cycle, vimentin or Notch expression in the U-87 MG cell line. 
After a 24-h incubation with the agonistic anti-Fas mAb 7C11 
(100 ng/ml), only 15% of cells were detected as apoptotic 
expressing cleaved caspase-3, assessing that U-87 MG cells 
are relatively resistant to apoptosis (Fig. 3A). In addition, 
using the same experimental conditions, no variation in cell 
cycle was observed (Fig. 3B). Vimentin, an immature cell 
marker, was detected in U-87 MG cells (14) by flow cytometry 
without change of its expression after anti-Fas 7C11 treatment 
(Fig. 3C).
Furthermore, Notch1 expression, the most implicated 
receptor of the Notch family in glioblastoma was studied in 
Fas-activating conditions in U-87 MG cells treated with 7C11 
(100 ng/ml) during 24 h. Fas activation did not modify Notch1 
expression that remained sequestered in the U-87 MG cells as 
under basal conditions (Fig. 3D).
Fas activation tends to increase p75NTR intracellular expres-
sion. While 20% of p75NTR was detected at the cell surface 
under a basal condition, activation of the Fas receptor by 
agonistic anti-Fas mAb 7C11, suppressed p75NTR membranous 
expression in all U-87 MG cells. Therefore, Fas-activation 
tended to increase (~10%) the percentage of cells expressing 
p75NTR in the intracellular compartment, compared to that in 
basal conditions (a total of 80% of cells expressed intracellular 
p75NTR vs. 70% under basal conditions) (Fig. 4).
γ-secretase inhibitor modifies Fas-induced apoptosis by 
p75NTR inhibiting pathway. To demonstrate that p75NTR inter-
acts with Fas-induced apoptosis, the γ-secretase inhibitor was 
incubated with or without 7C11 (100 ng/ml), and the apoptotic 
rate was determined by measurement of cytoplasmic soluble 
nucleosomes (Fig. 5) or membranous staining with Annexin V 
(data not shown). Fas activation by a 24-h exposure to agonistic 
anti-Fas mAb significantly induced apoptosis compared to 
the basal apoptotic level (p<0.0001) (Fig. 5). The γ-secretase 
inhibitor did not modify this apoptotic level in basal condi-
tions. However, concomitant treatment of U-87 MG cells 
with agonistic anti-Fas mAb and the γ-secretase inhibitor 
significantly decreased cell apoptosis compared to 7C11 alone 
(p=0.007) (Fig. 5).
Figure 1. Detection of Fas and p75NTR by flow cytometry in the U-87 MG 
cell line. (A) Extracellular domain of the Fas receptor was detected in 100% 
of U-87 MG cells at the membrane level using phycoerythrin-conjugated 
antibody (UB2 clone). (B) Intracellular domain of the Fas receptor was 
detected in 100% of U-87 MG cells after cell permeabilization using phy-
coerythrin-conjugated antibody (B-10 clone). (C) Extracellular domain of 
p75NTR was detected only in 15% of the U-87 MG cells at the membrane level 
using polyclonal antibody recognizing the extracellular domain of p75NTR 
revealed by anti-rabbit fluorescein isothiocyanate-conjugated antibody. 
(D) Extracellular domain of p75NTR was detected in 80% of U-87 MG cells after 
cell permeabilization.
  A   B
  C   D
  A
  B
  C
Figure 2. Detection of Notch1, 2 and their ligands by flow cytometry in the 
U-87 MG cell line. (A) Neither Notch1 nor Notch2 were detected by flow 
cytometry without cell permeabilization in U-87 MG cells. (B) Notch1 and 2 
were sequestered in the cytoplasm, and only detected after cell permeabiliza-
tion of U-87 MG cells. (C) Delta 1, Delta 4, Jagged 1 and Jagged 2 were only 
detected after cell permeabilization. These Notch ligands were sequestered 
in the U-87 MG cell cytoplasm.
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Discussion
We demonstrated herein that γ-secretase inhibitors decreased 
Fas-induced apoptosis in the human U-87 MG glioblastoma 
cell line. These cells expressed the full-length receptor of the 
Fas death receptor and its activation by an agonistic anti-Fas 
mAb induced significant apoptosis. Another death receptor, 
p75NTR, the low affinity receptor for neurotrophins, is known 
to be linked to the Fas receptor through a common signaling 
pathway as demonstrated in a neuroblastoma cell line. 
Indeed, when stimulated alone, i.e., Fas by FasL and p75NTR 
by the neurotrophin BDNF, each receptor induced cell death, 
whereas their concomitant activation was found to suppress 
apoptotic cell death, depending on simultaneous caspase-8 
and sphingomyelinase activation (4). However, BDNF-induced 
cell death through p75NTR activation alone was found to be 
Figure 3. Anti-Fas mAb 7C11 treatment promotes cell apoptosis without modifying the cell cycle, vimentin or Notch1 expression. After a 24-h exposure to 
anti-Fas mAb 7C11 (100 ng/ml) modification of cell apoptosis, cell cycle, vimentin or Notch1 expression was investigated. (A) Cell apoptosis was evaluated 
by cleaved caspase-3 expression detected by flow cytometry. Anti-Fas agonistic mAb treatment led to 15% of apoptotic cells in the U-87 MG cell line. (B) The 
cell cycle was not affected by Fas activation (7C11). Vimentin (C) and Notch1 (D) expression in U-87 MG cells was not modified by Fas activation (7C11).
  A   B
  C   D
Figure 4. Anti-Fas mAb 7C11 treatment tended to increase p75NTR intracel-
lular expression. Under a basal condition, 20% of U-87 MG cells expressed 
p75NTR at the membrane level and 70% of these cells expressed p75NTR in the 
intracellular compartment (left panel). By contrast, Fas activation suppressed 
p75NTR membrane expression and 80% of cells had an intracellular expression 
of this receptor (right panel).
Figure 5. γ-secretase inhibitor decreased Fas-induced apoptosis. U-87 MG 
cells were treated for 24 h with anti-Fas mAb 7C11, γ-secretase inhibitor 
or both molecules. The apoptotic rate was determined by measurement of 
cytoplasmic soluble nucleosomes. Anti-Fas mAb 7C11 promoted cell apop-
tosis compared to basal condition (p<0.0001); by contrast, the γ-secretase 
inhibitor alone did not significantly modify cell death, whereas it signifi-
cantly decreased 7C11-induced apoptosis (p=0.007). **p<0.01; ***p<0.001.
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inefficient in the U-87 MG glioblastoma cell line containing 
p75NTR receptor sequestered in Golgi apparatus (13).
By contrast, p75NTR was found to be involved as an activator 
of tumor invasion, mediated through intra-membranous prote-
olysis by α and γ-secretase, releasing the intracellular domain 
that binds the nucleus and activates signal transduction (8,6). 
This tumor invasion was inhibited by γ-secretase inhibitor 
in vitro and in experimental models in a BDNF-dependent 
mechanism (7). Nevertheless, this antitumor effect was not 
evaluated under cell death activation through Fas activation in 
glioblastoma cells. Indeed, the interaction of Fas and p75NTR (4) 
during cell-induced apoptosis may be modified. On the other 
hand, γ-secretase is known to cleave other proteins, including 
Notch receptors (10). 
Notch signaling is well known to play a key role during 
normal and neoplastic development (15,16). Perturbation of 
the Notch signaling pathway may often lead to the process 
of carcinogenesis, including glioblastoma (17). The Notch 
signaling pathway requires γ-secretase cleavage resulting in 
Notch intracellular domain translocation in the nucleus and 
activation of transcription. For this reason, we investigated 
Notch1 and 2 expression in U-87 MG cells. Indeed, intracel-
lular expression of Notch1, 2 and their ligands was detected in 
the U-87 MG cell line without membranous location and was 
not modified by Fas-activation.
In a human neuroblastoma cell line, p75NTR was demon-
strated to induce cell death after BDNF stimulation and to 
interact with the Fas receptor (4). Likewise, our results suggest 
a potential interaction between Fas and p75NTR in the U-87 MG 
human glioblastoma cell line. Indeed, γ-secretase inhibitor 
significantly decreased apoptosis induced through Fas activa-
tion. These results suggest that γ-secretase is implicated in the 
cell death induced by Fas activation through p75NTR cleavage 
and signaling. Such p75NTR involvement in apoptosis was 
described in primary neuronal cell cultures in which p75NTR 
cleavage by γ-secretase resulted in nuclear translocation of 
the intracellular domain and apoptotic cell death (18). 
The present results are in agreement with Fas and p75NTR 
interactions in glioblastoma cells. Therefore we hypoth-
esized that the γ-secretase inhibitor diminishes Fas-induced 
apoptosis depending on its interaction with p75NTR through 
its intracellular domain. Such mechanisms interfering with 
Fas activation will be of great importance in the search for 
cell death-inducing treatment. Indeed, whereas glioblastoma 
cells are spontaneously resistant to cell death induction, it was 
previously demonstrated that a combination of Fas activation 
with concomitant etoposide plus dexamethasone exhibits 
antiproliferative and antitumor properties in experimental 
glioblastoma in the nude rat (3). We hypothesize that Fas and 
p75NTR activation are of major importance in apoptosis induc-
tion of glioma cells, and that the γ-secretase inhibitor may 
interfere with Fas-activating treatment.
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